Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

COVID-19

Free Subscription 04.03.2024 1 Am J Obstet Gynecol 1 Ann Intern Med 1 Antiviral Res 3 BMJ 2 Clin Infect Dis 5 Emerg Infect Dis 5 Int J Infect Dis 3 J Med Virol 2 J Virol 1 JAMA 1 Lancet 2 Lancet Infect Dis 1 Life Sci 3 MMWR Morb Mortal Wkly Rep 3 N Engl J Med 2 Nature 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. SHIVRAJ P, Chadha R, Kincaid H, Sparks A, et al
   Impact of the COVID-19 Pandemic on Fellowship Research.
   Am J Obstet Gynecol. 2024 Feb 27:S0002-9378(24)00374.
   PubMed        
   
   

   
   Ann Intern Med

2. PAULES CI, Wang J, Tomashek KM, Bonnett T, et al
   A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2.
   Ann Intern Med. 2024 Feb 27. doi: 10.7326/M23-2593.
   PubMed         Abstract available
   
   

   
   Antiviral Res

3. LI H, Sun M, Lei F, Liu J, et al
   Methyl rosmarinate is an allosteric inhibitor of SARS-cov-2 3?C?L protease as a potential candidate against SARS-cov-2 infection.
   Antiviral Res. 2024 Feb 24:105841. doi: 10.1016/j.antiviral.2024.105841.
   PubMed         Abstract available
   
   

   
   BMJ

4. WISE J
   Covid-19 taskforce called for a new national vaccine agency to prepare for future pandemics.
   BMJ. 2024;384:q534.
   PubMed        
   
   
5. BENTLEY-EDWARDS KL, Adisa O, Ruff KE, McClure ES, et al
   Race, racism, and covid-19 in the US: lessons not learnt.
   BMJ. 2024;384:e076106.
   PubMed        
   
   
6. WISE J
   Covid-19: Two rare vaccine side effects detected in large global study.
   BMJ. 2024;384:q488.
   PubMed        
   
   

   
   Clin Infect Dis

7. SHAH MM, Joyce B, Plumb ID, Sahakian S, et al
   Combined protection of vaccination and nirmatrelvir-ritonavir against hospitalization in adults with COVID-19.
   Clin Infect Dis. 2024 Feb 27:ciae105. doi: 10.1093.
   PubMed         Abstract available
   
   
8. NIMGAONKAR I, Yoke LH, Roychoudhury P, Flaherty PW, et al
   Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T Cell Therapy Recipients with Pre-Cellular Therapy SARS-CoV-2 Infection.
   Clin Infect Dis. 2024 Mar 1:ciae116. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Emerg Infect Dis

9. PATERSON A, Cheyne A, Jones B, Schilling S, et al
   Systematic Review of Scales for Measuring Infectious Disease-Related Stigma.
   Emerg Infect Dis. 2024;30:519-529.
   PubMed         Abstract available
   
   
10. OGOTI BM, Riitho V, Wildemann J, Mutono N, et al
    Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022-2023.
    Emerg Infect Dis. 2024;30:581-585.
    PubMed         Abstract available
    
    
11. VU QM, Fitzpatrick AL, Cope JR, Bertolli J, et al
    Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection.
    Emerg Infect Dis. 2024;30:539-547.
    PubMed         Abstract available
    
    
12. KECK JW, Adatorwovor R, Liversedge M, Mijotavich B, et al
    Wastewater Surveillance for Identifying SARS-CoV-2 Infections in Long-Term Care Facilities, Kentucky, USA, 2021-2022.
    Emerg Infect Dis. 2024;30:530-538.
    PubMed         Abstract available
    
    
13. VON MOLLENDORF C, Ulziibayar M, Nguyen CD, Batsaikhan P, et al
    Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2-59 Months of Age, Mongolia, 2015-2021.
    Emerg Infect Dis. 2024;30:490-498.
    PubMed         Abstract available
    
    

    
    Int J Infect Dis

14. SYLVAIN L, Donatien K, Kadidia K, Viviane C, et al
    SARS-CoV-2 seroprevalence in vaccine-naive participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali.
    Int J Infect Dis. 2024 Feb 26:106985. doi: 10.1016/j.ijid.2024.106985.
    PubMed         Abstract available
    
    
15. DADU A, Yedilbayev A, Migliori GB, Ahmedov S, et al
    PASS to End TB in Europe: Accelerated efforts on Prevention and Systematic Screening to End Tuberculosis in the WHO European Region by 2030.
    Int J Infect Dis. 2024 Feb 23:S1201-9712(24)00051.
    PubMed         Abstract available
    
    
16. FURST T, Bazalova A, Frycak T, Janosek J, et al
    Does the healthy vaccinee bias rule them all? Association of COVID-19 vaccination status and all cause mortality from an analysis of data from 2.2 million individual health records.
    Int J Infect Dis. 2024 Feb 22:S1201-9712(24)00046.
    PubMed         Abstract available
    
    
17. HUANG L, Tong X, Cui J, Du X, et al
    Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma: A case series.
    Int J Infect Dis. 2024;141:106973.
    PubMed         Abstract available
    
    
18. PETRAS M, Janovska D, Lomozova D, Franklova M, et al
    Understanding the time-driven shifts of vaccine effectiveness against any and severe COVID-19 before and after the surge of Omicron variants within 2.5 years of vaccination: a meta-regression.
    Int J Infect Dis. 2024 Feb 26:106986. doi: 10.1016/j.ijid.2024.106986.
    PubMed         Abstract available
    
    

    
    J Med Virol

19. WU P, Yii CY, Yong SB
    Comment on "The risk assessment of uveitis after COVID-19 diagnosis".
    J Med Virol. 2024;96:e29494.
    PubMed        
    
    
20. XIAO J, Luo Y, Li Y, Yao X, et al
    The characteristics of BCR-CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccinated volunteers.
    J Med Virol. 2024;96:e29488.
    PubMed         Abstract available
    
    
21. ZHANG N, Ye Z, Li C, Zhou J, et al
    A subunit-based influenza/SARS-CoV-2 Omicron combined vaccine induced potent protective immunity in BALB/c mice.
    J Med Virol. 2024;96:e29479.
    PubMed         Abstract available
    
    

    
    J Virol

22. HE H, Li Y, Chen Y, Chen J, et al
    NLRP1 restricts porcine deltacoronavirus infection via IL-11 inhibiting the phosphorylation of the ERK signaling pathway.
    J Virol. 2024 Feb 27:e0198223. doi: 10.1128/jvi.01982.
    PubMed         Abstract available
    
    
23. MARTINS M, Nooruzzaman M, Cunningham JL, Ye C, et al
    The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.
    J Virol. 2024 Feb 29:e0190223. doi: 10.1128/jvi.01902.
    PubMed         Abstract available
    
    

    
    JAMA

24. ANDERSSON NW, Thiesson EM, Hviid A
    Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
    JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036.
    PubMed        
    
    

    
    Lancet

25. DHAIRYAWAN R
    Candour, care, and COVID-19.
    Lancet. 2024;403:718.
    PubMed        
    
    

    
    Lancet Infect Dis

26. HANSEN CH, Moustsen-Helms IR, Rasmussen M, Soborg B, et al
    Non-COVID-19 hospitalisation as a negative control outcome in COVID-19 vaccine effectiveness studies - Authors' reply.
    Lancet Infect Dis. 2024 Feb 22:S1473-3099(24)00107.
    PubMed        
    
    
27. POUKKA E, Auranen K, Baum U
    Non-COVID-19 hospitalisation as a negative control outcome in COVID-19 vaccine effectiveness studies.
    Lancet Infect Dis. 2024 Feb 22:S1473-3099(24)00106.
    PubMed        
    
    

    
    Life Sci

28. YOUSEF M, Rob M, Varghese S, Rao S, et al
    The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
    Life Sci. 2024;342:122535.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

29. ESSER MB, Sherk A, Liu Y, Naimi TS, et al
    Deaths from Excessive Alcohol Use - United States, 2016-2021.
    MMWR Morb Mortal Wkly Rep. 2024;73:154-161.
    PubMed         Abstract available
    
    
30. FRUTOS AM, Price AM, Harker E, Reeves EL, et al
    Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
    MMWR Morb Mortal Wkly Rep. 2024;73:168-174.
    PubMed         Abstract available
    
    
31. DECUIR J, Payne AB, Self WH, Rowley EAK, et al
    Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged >/=18 Years - VISION and IVY Networks,
    MMWR Morb Mortal Wkly Rep. 2024;73:180-188.
    PubMed         Abstract available
    
    

    
    N Engl J Med

32. HAMPSHIRE A, Azor A, Atchison C, Trender W, et al
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:806-818.
    PubMed         Abstract available
    
    
33. AL-ALY Z, Rosen CJ
    Long Covid and Impaired Cognition - More Evidence and More Work to Do.
    N Engl J Med. 2024;390:858-860.
    PubMed        
    
    
34. ELLINGJORD-DALE M, Brunvoll SH, Soraas A
    Prospective Memory Assessment before and after Covid-19.
    N Engl J Med. 2024;390:863-865.
    PubMed        
    
    

    
    Nature

35. CARLSON C, Becker D, Happi C, O'Donoghue Z, et al
    Save lives in the next pandemic: ensure vaccine equity now.
    Nature. 2024;626:952-953.
    PubMed        
    
    
36. JAMOULLE M, Louazon E, Antonacci T, Van Weyenbergh J, et al
    Speed up relief for long COVID through grassroots clinical trials.
    Nature. 2024;626:954.
    PubMed        
    
    

    
    Science

37. AL-ALY Z, Topol E
    Solving the puzzle of Long Covid.
    Science. 2024;383:830-832.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.